Deaths Linked to Japanese Supplement Suddenly Rises to 80
New York Times
The case, involving a supplement intended to reduce cholesterol, has put attention on how companies are allowed to self-report claims about their products.
https://www.nytimes.com/2024/06/28/business/kobayashi-pharmaceutical-supplement-deaths.html